Stocks · News reference

Maxim Group Maintains Buy on Health In Tech, Lowers Price Target to $3

Aug 14, 2026, 8:18 PMBenzinga Newsdesk

Maxim Group analyst Allen Klee maintains Health In Tech (NASDAQ:HIT) with a Buy and lowers the price target from $4 to $3.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 13, 2026, 10:08 PMBenzinga Insights
Health In Tech Q2 2026 Earnings Call: Complete Transcript
Health In Tech (NASDAQ:HIT) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
Read original at benzinga
HIT
SEC EDGARAug 13, 2026, 9:17 PMSEC EDGAR
8-K filing — Health In Tech, Inc. (HIT)
Filed: 2026-08-13 AccNo: 0001213900-26-089249 Size: 268 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgar
HIT
BenzingaAug 13, 2026, 8:31 PMBenzinga Newsdesk
Health In Tech Affirms FY2026 Sales Guidance of $45.000M-$50.000M vs $46.813M Est
Health In Tech (NASDAQ:HIT) affirms FY2026 sales outlook from $45.000 million-$50.000 million to $45.000 million-$50.000 million vs $46.813 million estimate.
Read original at benzinga
HIT